Anagrelide Hydrochloride Anhydrous is the hydrochloride salt of a synthetic quinazoline derivative, Anagrelide Hydrochloride reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic AMP phosphodiesterase, as well as ADP- and collagen-induced platelet aggregation. At therapeutic doses, it does not influence white cell counts or coagulation parameters. Anagrelide is used for treatment of essential thrombocythemia to reduce elevated platelet counts and the risk of thrombosis. It is grouped under the following drug class(es): Antiplatelets. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Anagrelide HCL, Thromboreductin, Xagrid and Agrelin. Its PubChem CID is 135413494.
Anagrelide hydrochloride
| CAS No | 58579-51-4 |
|---|---|
| Molecular Formula | C10H8Cl3N3O |
| Molecular Weight | 292.5 g/mol |
| Synonyms | 6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Anagrelide Hydrochloride Anhydrous is the hydrochloride salt of a synthetic quinazoline derivative, Anagrelide Hydrochloride reduces platelet production through a decrease in megakaryocyte maturation.
The listed CAS number is 58579-51-4.
The listed molecular formula is C10H8Cl3N3O.
The listed molecular weight is 292.5 g/mol.
6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one;hydrochloride.
The source lists Anagrelide HCL, Thromboreductin, Xagrid and Agrelin.